Blog
RSS FeedPosted by Michael Wonder on 11 Jun 2019
Two additional countries to benefit from EU-US mutual recognition agreement for inspections
11 June 2019 - On 10 June 2019, Luxembourg and the Netherlands were included into the mutual recognition agreement between ...
Posted by Michael Wonder on 28 May 2019
PHARMAC head defends drug agency's funding
28 May 2019 - PHARMAC is under intense pressure from clinicians, health advocacy groups and patients to fund more medicines ...
Posted by Michael Wonder on 27 May 2019
Medicines Australia welcomes Morrison Government Ministry
26 May 2019 - Medicines Australia welcomes the appointment of the Morrison Government Ministry following the May 18 Federal Election. ...
Posted by Michael Wonder on 16 May 2019
Will drugs companies follow EU agency from London to Amsterdam?
16 May 2019 - Amid the bustling skyscrapers of London’s Canary Wharf, one building stands silent and shuttered — a ...
Posted by Michael Wonder on 14 May 2019
EMA begins search for next Executive Director
14 May 2019 - As Guido Rasi wraps up his second five-year term as the executive director of the European ...
Posted by Michael Wonder on 03 Apr 2019
Institute for Clinical and Economic Review Appoints Dr. Pamela Bradt as Chief Scientific Officer
2 April 2019 - The Institute for Clinical and Economic Review has announced the appointment of Pamela Bradt as the organization's ...
Posted by Michael Wonder on 23 Mar 2019
Senate panel to hear from pharmacy middlemen on drug prices
21 March 2019 - The Senate Finance Committee said Thursday that it has secured commitments from executives of five major ...
Posted by Michael Wonder on 19 Mar 2019
Institute for Clinical and Economic Review appoints new members to each of its three independent evidence appraisal councils
18 March 2019 - New members bring expertise in broad range of perspectives, including patient advocacy, health policy, economics, and clinical ...
Posted by Michael Wonder on 12 Mar 2019
Cancer Institute's Sharpless tapped as acting chief of FDA
12 March 2019 - Ned Sharpless, the director of the National Cancer Institute, will be named temporary chief of the ...
Posted by Michael Wonder on 06 Mar 2019
Donald Trump just lost his most popular bureaucrat
6 March 2019 - U.S. FDA Commissioner Scott Gottlieb is resigning and will leave the agency in a month, according to ...
Posted by Michael Wonder on 06 Mar 2019
FDA chief tough on e-cigs steps down in surprise resignation
5 March 2019 - U.S. FDA Commissioner Scott Gottlieb said on Tuesday that he plans to step down next month, a ...
Posted by Michael Wonder on 31 Jan 2019
CEOs hide as pressure on drug prices grows
30 January 2019 - This week, key committees in the House and Senate each held hearings on the rising cost ...
Posted by Michael Wonder on 16 Jan 2019
The FDA has five weeks till money runs out for approving new drugs
16 January 2019 - The US FDA has roughly five weeks of funding left to review new drug applications during ...
Posted by Michael Wonder on 16 Jan 2019
EMA to lose 25% of staff as hard Brexit approaches
14 January 2019 - As UK Prime Minister Theresa May’s Brexit deal is expected to be rejected Tuesday in a ...
Posted by Michael Wonder on 15 Jan 2019
If the shutdown drags on at FDA, it will put anticipated new treatments in jeopardy
14 January 2019 - The government shutdown could soon jeopardise highly anticipated new drugs from Janssen, Sanofi, and Novartis for ...